Phase I Study of the Bifunctional Fusion Protein Bintrafusp Alfa in Asian Patients with Advanced Solid Tumors, Including a Hepatocellular Carcinoma Safety-Assessment Cohort — Toshihiko Doi (2020) | RDL Network
Phase I Study of the Bifunctional Fusion Protein Bintrafusp Alfa in Asian Patients with Advanced Solid Tumors, Including a Hepatocellular Carcinoma Safety-Assessment Cohort
Article 2020 en
Authors
TD
Toshihiko Doi
YF
Yutaka Fujiwara
TK
Takafumi Koyama
Abstract
1 min read
Bintrafusp alfa had a manageable safety profile and preliminary efficacy in heavily pretreated patients with advanced solid tumors, including HCC.
Ignacio Melero, Bruno Sangro, Thomas Cheung Yau, Chiun Hsu, Masatoshi Kudo, Todd S. Crocenzi, Tae‐You Kim, Su Pin Choo, Jörg Trojan, Tim Meyer, Theodore H. Welling, Winnie Yeo, Akhil Chopra, Jeffrey Anderson, Christine Marie Dela Cruz, Lixin Lang, Jaclyn Neely, Hao Tang, Anthony B. El-Khoueiry
Sophie Cousin, Jean Yves Blay, Irene García, Johann S. de Bono, Christophe Le Tourneau, Víctor Moreno, José Trigo, Christine L. Hann, Arun Azad, Seock‐Ah Im, Geraldine Ferron‐Brady, Antara Datta, Yuehui Wu, Thierry Horner, Brandon E. Kremer, Arindam Dhar, Peter J. O’Dwyer, Geoffrey I. Shapiro, Sarina A. Piha‐Paul
Discussion(0)
No comments yet. Be the first to comment.